PETER J. LANGECKER, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-28 PETER J. LANGECKER, M.D., PH.D. Age: 59 Director Since: 2010 ... Dr. Langecker joined OXiGENE as Executive Vice President and Chief Development Officer in June 2009 and was appointed Chief Executive Officer in October 2009 ... Director Compensation table does not list Peter J. Langecker's compensation for 2009.
2011-09-22 Dr. Langecker joined OXiGENE as Executive Vice President and Chief Development Officer in June 2009 and was appointed Chief Executive Officer in October 2009... Summary Compensation Table: Peter Langecker, Chief Executive Officer, 2010 salary $350,000, stock awards $132,825, other compensation $929... Total compensation approximately $483,754.
2012-04-20 PETER J. LANGECKER,M.D., PH.D. Age: 61 Director Since: 2010 Principal Occupation: Dr. Langecker joined OXiGENE as Executive Vice President and Chief Development Officer in June 2009 and was appointed Chief Executive Officer in October 2009. He became Chairman of our Board of Directors in October 2011. ... Director Compensation Table does not list compensation for Dr. Langecker as he is an employee. ... Summary Compensation Table shows total compensation of $536,025.
2013-06-13 Dr. Langecker joined OXiGENE as Executive Vice President and Chief Development Officer in June 2009 and was appointed Chief Executive Officer in October 2009. He became Chairman of our Board of Directors in October 2011. ... The following table shows the total compensation paid or accrued during the fiscal year ended December 31, 2012 to each of our non-employee directors. ... Peter Langecker Chief Executive Officer: $552,082.
2014-04-30 Dr. Langecker joined OXiGENE as Executive Vice President and Chief Development Officer in June 2009 and was appointed Chief Executive Officer in October 2009. He served as Chairman of our Board of Directors from October 2011 until Mr. Driscoll's appointment in January 2014. Dr. Langecker is employed by the Company and is not compensated for his service as a director.

Data sourced from SEC filings. Last updated: 2026-02-03